Bayer vs Gallene Sciences: David vs Goliath?

The German multinational may be using a legal excuse to eliminate one of their future biggest competitors

Bayer vs Gallene Science: David vs Goliath?

The Latin American Post received access to an email that AZB & Partners, a legal office in Mumbai, India, sent to Gallene Sciences. The office assured that they are the legal representatives of Bayer AG in said country.

According to AZB, Gallene Sciences illegally used the Bayer's trademark "Science for a better life" looking to confuse the people "bringing about association with our client and to pass off your goods which fall under the same category". The law firm also accused the Indian laboratory of using similar colors in its logo, green and blue.

However, Bayer is well known and it possesses powerful worldwide influence, due to this it seems as if this is a legal excuse for the German company, “Goliath”, to eliminate Gallene,“David”.

There are some similarities in the colors between both companies, but that doesn’t mean that there was an infringement of the law. For example, Pfizer, Boehringer Ingelheim, and Roche, three of the biggest names in the pharmaceutical world, use blue and white due to their association to science. Merck also uses blue and green like Bayer, but they haven’t been taken into court by the corporation giant.

AZB threatened Gallene Sciences that if they didn’t comply with the requests, which include the "[the removal of] all references of 'Science for a better life'" and bringing down the color combination of their website, they would take legal action.

The consequences of the legal dispute will affect he who seems to be the underdog. The legal fees will affect the research and the economic stability of the company, favoring Bayer in the market.

India, the biggest threat to the western laboratories

An expert on the topic. who was consulted by the Latin American Post, stated that the Indian laboratories "are the biggest threat to the mainstream laboratories. In India, the workforce is cheaper than in the developed countries and they also have the same devices, so they can copy the same medicine or drugs, and produce them way cheaper". This reduction of the prices benefits the consumer, especially in developing countries, but affects the profit of large pharmaceutical organizations.

It was explained that Indian and Chinese laboratories don’t violate the copyrights because the use and develop a different path to produce the same molecule. They produce the well-known "generic medicines".


Latin American Post | Editorial Team 

We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…